Literature DB >> 16421894

Warfarin resistance in a French strain of rats.

Romain Lasseur1, Christiane Longin-Sauvageon, Bernadette Videmann, Mikaëline Billeret, Philippe Berny, Etienne Benoit.   

Abstract

A warfarin-resistant strain and a warfarin-susceptible strain of wild rats (Rattus norvegicus) maintained in enclosures of the National Veterinary School of Lyon (France) were studied to determine the mechanism of the resistance to anticoagulant rodenticides. A low vitamin K epoxide reductase (VKOR) activity has been reported for many resistant rat strains. As recently suggested, mutations in the vitamin K epoxide reductase subunit 1 (VKORC1) gene are the genetic basis of anticoagulant resistance in wild populations of rats from various locations in Europe. Here we report, for our strain, one of the seven described mutations (Tyr139Phe) for VKORC1 in rats. In addition, a low expression of mRNA encoding VKORC1 gene is observed in resistant rats, which could explain their low VKOR activity. We calculated kinetic parameters of VKOR in the warfarin-resistant and warfarin-susceptible rats. The V(max) and the K(m) of the VKOR obtained in resistant rats were lowered by 57 and 77%, respectively, compared to those obtained in susceptible rats. As a consequence, the enzymatic efficiency (V(m)/K(m)) of the VKOR was similar between resistant and susceptible rats. This result could be a good explanation to the observation that no clinical signs of vitamin K deficiency was observed in the warfarin-resistant strain, while a low VKOR activity was found. VKOR activity in warfarin-resistant rats was poorly inhibited by warfarin (K(i) for warfarin is 29 microM and 0.72 microM for resistant and susceptible rats, respectively). (c) 2005 Wiley Periodicals, Inc. J Biochem Mol Toxicol 19:379-385, 2005

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16421894     DOI: 10.1002/jbt.20104

Source DB:  PubMed          Journal:  J Biochem Mol Toxicol        ISSN: 1095-6670            Impact factor:   3.642


  15 in total

1.  Are water vole resistant to anticoagulant rodenticides following field treatments?

Authors:  Julie Vein; Agnès Grandemange; Jean-François Cosson; Etienne Benoit; Philippe J Berny
Journal:  Ecotoxicology       Date:  2011-06-01       Impact factor: 2.823

2.  Mycobacterium tuberculosis vitamin K epoxide reductase homologue supports vitamin K-dependent carboxylation in mammalian cells.

Authors:  Jian-Ke Tie; Da-Yun Jin; Darrel W Stafford
Journal:  Antioxid Redox Signal       Date:  2011-11-22       Impact factor: 8.401

Review 3.  Evolutionary rescue in vertebrates: evidence, applications and uncertainty.

Authors:  E Vander Wal; D Garant; M Festa-Bianchet; F Pelletier
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-01-19       Impact factor: 6.237

4.  A hetero-dimer model for concerted action of vitamin K carboxylase and vitamin K reductase in vitamin K cycle.

Authors:  Sangwook Wu; Shubin Liu; Charles H Davis; Darrel W Stafford; John D Kulman; Lee G Pedersen
Journal:  J Theor Biol       Date:  2011-03-29       Impact factor: 2.691

5.  Consequences of the Y139F Vkorc1 mutation on resistance to AVKs: in-vivo investigation in a 7th generation of congenic Y139F strain of rats.

Authors:  Agnes Grandemange; Michael Hans Kohn; Romain Lasseur; Christiane Longin-Sauvageon; Philippe Berny; Etienne Benoit
Journal:  Pharmacogenet Genomics       Date:  2009-10       Impact factor: 2.089

6.  VKORC1L1, an enzyme rescuing the vitamin K 2,3-epoxide reductase activity in some extrahepatic tissues during anticoagulation therapy.

Authors:  Abdessalem Hammed; Benjamin Matagrin; Gabriele Spohn; Caroline Prouillac; Etienne Benoit; Virginie Lattard
Journal:  J Biol Chem       Date:  2013-08-08       Impact factor: 5.157

7.  Evaluation of oral anticoagulants with vitamin K epoxide reductase in its native milieu.

Authors:  Xuejie Chen; Da-Yun Jin; Darrel W Stafford; Jian-Ke Tie
Journal:  Blood       Date:  2018-08-08       Impact factor: 22.113

8.  Warfarin and vitamin K epoxide reductase: a molecular accounting for observed inhibition.

Authors:  Sangwook Wu; Xuejie Chen; Da-Yun Jin; Darrel W Stafford; Lee G Pedersen; Jian-Ke Tie
Journal:  Blood       Date:  2018-05-09       Impact factor: 22.113

9.  Novel mutations in the VKORC1 gene of wild rats and mice--a response to 50 years of selection pressure by warfarin?

Authors:  Simone Rost; Hans-Joachim Pelz; Sandra Menzel; Alan D MacNicoll; Vanina León; Ki-Joon Song; Thomas Jäkel; Johannes Oldenburg; Clemens R Müller
Journal:  BMC Genet       Date:  2009-02-06       Impact factor: 2.797

10.  New insights into the catalytic mechanism of vitamin K epoxide reductase (VKORC1) - The catalytic properties of the major mutations of rVKORC1 explain the biological cost associated to mutations.

Authors:  Benjamin Matagrin; Ahmed Hodroge; Adrien Montagut-Romans; Julie Andru; Isabelle Fourel; Stéphane Besse; Etienne Benoit; Virginie Lattard
Journal:  FEBS Open Bio       Date:  2013-02-16       Impact factor: 2.693

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.